Literature DB >> 21300093

Vaccination with the defined chlamydial secreted protein CPAF induces robust protection against female infertility following repeated genital chlamydial challenge.

Ashlesh K Murthy1, Weidang Li, M Neal Guentzel, Guangming Zhong, Bernard P Arulanandam.   

Abstract

We previously have shown the efficacy of recombinant (r) chlamydial protease-like activity factor (CPAF) vaccination against hydrosalpinx development following primary genital chlamydial challenge. In this study, we evaluated further the protection induced by rCPAF vaccination against infertility. Following primary challenge, fertility levels were not significantly different between the mock- and CPAF-vaccinated and Chlamydia alone challenged mice. However, following secondary genital chlamydial challenge, mock (PBS) immunized mice displayed a significant reduction of fertility compared to age-matched naïve mice, while mice vaccinated intranasally with rCPAF+CpG displayed significant prevention of infertility. These results suggest that hydrosalpinx may be a reliable indicator of impending infertility, and that rCPAF is a promising candidate to prevent infertility resulting from repeated genital chlamydial infections.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300093      PMCID: PMC3214972          DOI: 10.1016/j.vaccine.2011.01.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele.

Authors:  Ashlesh K Murthy; Yu Cong; Cathi Murphey; M Neal Guentzel; Thomas G Forsthuber; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

4.  Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.

Authors:  Feng Dong; Youmin Zhong; Bernard Arulanandam; Guangming Zhong
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 5.  Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.

Authors:  Robert C Brunham; José Rey-Ladino
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

Review 6.  Immunopathogenesis of chlamydia trachomatis infections in women.

Authors:  Joseph Debattista; Peter Timms; John Allan; Janet Allan
Journal:  Fertil Steril       Date:  2003-06       Impact factor: 7.329

7.  Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge.

Authors:  Bharat K R Chaganty; Ashlesh K Murthy; Shankar J Evani; Weidang Li; M Neal Guentzel; James P Chambers; Guangming Zhong; Bernard P Arulanandam
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

8.  Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.

Authors:  Weidang Li; M Neal Guentzel; J Seshu; Guangming Zhong; Ashlesh K Murthy; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

9.  Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice.

Authors:  Ashlesh K Murthy; Jyotika Sharma; Jacqueline J Coalson; Guangming Zhong; Bernard P Arulanandam
Journal:  Cell Immunol       Date:  2004-07       Impact factor: 4.868

10.  Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.

Authors:  Yu Cong; Madhulika Jupelli; M Neal Guentzel; Guangming Zhong; Ashlesh K Murthy; Bernard P Arulanandam
Journal:  Vaccine       Date:  2007-02-23       Impact factor: 3.641

View more
  24 in total

1.  Antigen-Specific CD4+ T Cell-Derived Gamma Interferon Is Both Necessary and Sufficient for Clearing Chlamydia from the Small Intestine but Not the Large Intestine.

Authors:  Hui Lin; Conghui He; John J Koprivsek; Jianlin Chen; Zhiguang Zhou; Bernard Arulanandam; Zhenming Xu; Lingli Tang; Guangming Zhong
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Al-Mutassim Hani Abu-Khdeir; Zhi Huo; Xin Sun; Nu Zhang; Robert Schenken; Yufeng Wang; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 3.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 4.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

5.  Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice.

Authors:  Weidang Li; Pareesha Gudipaty; Chuxi Li; Kyle K Henderson; Kyle H Ramsey; Ashlesh K Murthy
Journal:  Immunol Cell Biol       Date:  2018-08-23       Impact factor: 5.126

6.  Lack of long-lasting hydrosalpinx in A/J mice correlates with rapid but transient chlamydial ascension and neutrophil recruitment in the oviduct following intravaginal inoculation with Chlamydia muridarum.

Authors:  Hongbo Zhang; Zhou Zhou; Jianlin Chen; Ganqiu Wu; Zhangsheng Yang; Zhiguang Zhou; Joel Baseman; Jin Zhang; Robert Lee Reddick; Guangming Zhong
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

7.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

8.  A T cell epitope-based vaccine protects against chlamydial infection in HLA-DR4 transgenic mice.

Authors:  Weidang Li; Ashlesh K Murthy; Gopala Krishna Lanka; Senthilnath L Chetty; Jieh-Juen Yu; James P Chambers; Guangming Zhong; Thomas G Forsthuber; M Neal Guentzel; Bernard P Arulanandam
Journal:  Vaccine       Date:  2013-10-01       Impact factor: 3.641

9.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

10.  Statins reduce spirochetal burden and modulate immune responses in the C3H/HeN mouse model of Lyme disease.

Authors:  Tricia A Van Laar; Camaron Hole; S L Rajasekhar Karna; Christine L Miller; Robert Reddick; Floyd L Wormley; J Seshu
Journal:  Microbes Infect       Date:  2016-03-16       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.